Block.one, the corporate behind EOSIO (EOS), issued a $50,000 grant to Genobank for its open-source app on April 29. The grant is designed to facilitate nameless entry to COVID-19 testing.
Genobank introduced in the beginning of April that its app, Agerona, was being developed alongside the Eos-based blockchain platform, Telos.
Block.one issued the grant in partnership with its enterprise capital wing, EOS VC, and German fintech incubator, FinLab EOS VC.
Block.one invests in Eos-based COVID-19 testing app
Agerona connects customers anonymously with take a look at suppliers of their nation. Checks comprise distinctive barcodes that create a free and nameless account on the Telos blockchain for the consumer. Kits are then despatched to a verified lab for processing — with outcomes anonymously uploaded to the blockchain.
The system permits for take a look at outcomes to then be analyzed by well being researchers, with out being tied to the id of the people examined.
Genobank CEO Daniel Uribe acknowledged: “[W]e are grateful to have the backing and help of Block.one’s enterprise arm EOS VC in aiding our efforts to anonymize DNA/RNA take a look at kits (together with coronavirus) whereas empowering sufferers and customers to resolve if they need their anonymized knowledge to be accessible to the scientific group and assist management the unfold of the coronavirus and doubtlessly contribute to a remedy.”
Block.one chief govt Brendan Blumer acknowledged: “We’ve witnessed the expansion of an open-source group whose ardour and innovation have helped to establish and resolve crucial enterprise issues in sectors starting from artwork to wellness.”
Block.one invests in a number of corporations preventing coronavirus
Block.one has funded a number of firms which are engaged on options to issues regarding COVID-19. The corporate has achieved this via its partnership with the EOS VC Grants program, and its partnership with FinLab EOS VC.
The recipients embody well being and wellness platform, PUML Higher Well being, the job-listing platform, Moonlighting, and the AI service, Innoplexus.
“With the onset of pressing world points attributable to the coronavirus, it is vital that we empower and help the ways in which blockchain know-how is being utilized to supply options,” acknowledged Blumer.
Use-cases for blockchain highlighted amid coronavirus pandemic
Most of the advantages of distributed ledger know-how, or DLT, have been showcased by current initiatives responding to COVID-19.
On April 29, the UK’s Open College started testing a blockchain-based proof-of-immunity app for COVID-19. The prototype seeks to guard privateness whereas offering tamper-resistant take a look at outcomes to confirm immunity.
On April 26, Cointelegraph reported that New York’s largest hospital community had joined IBM’s Fast Provider Join community — a blockchain-based community for verifying suppliers of COVID-19 aid items, and connecting suppliers with purchasers.
Throughout April, ConsenSys builders engaged on Baseline Protocol have advised a system for coronavirus contact tracing. They goal to handle potential privateness, record-falsification, and knowledge centralization dangers recognized in proposals from Apple and Google.
Credit score: Source link